您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:归创通桥-B年报 2024 - 发现报告

归创通桥-B年报 2024

2025-04-29 港股财报 MEI.
报告封面

22 270 270 33191928 9925-28 128 H1617 9984 H02190 432 www.zyloxtb.com 1811 20248004720800,000AI 2024— 2024782.5202348.3%74.5%38.4%48.0%58.2% 100.3 2024 202410 2024 2024 2024 (i)(ii)(iii)(iv) 202412 31(CRD)UltraFreePTA(UltraFree DCB) H I. 2024 782.52023527.848.3%67.7%32.3% 2024202338.4%(i)CRDSS(ii) 2024202374.5%(i)UltraFreePTA(UltraFree DCB)ZYLOX OctoplusZYLOX Swan(ii)ZYLOX PhoenixZYLOX Penguin2024 2024124.0100.3 1. 2024202448.3%4720203,000800,000 20236DCB3.5202453+NAB2.5 2024202520242025PTA(Rx) 2. 202422.6202358.2% 2420ZYLOX PenguinCEMDR 20242024(WLNC2024)2024(LINC 2024)(CIRSE2024) 3. 2021402024 ——ZYLOX PenguinZYLOX SwanZYLOX Octoplus—ZYLOX Unicorn5F26F UberVanaDCBPTAPTA 4. 2024100.3 202471.6% 202331.0%202422.3% 2024233.22023261.010.6% 2023114.1202491.0 6647CE(UAE) 232027 (CRD)(BGC)BADDASSBADDASSBAlloon guide with large boreDistal access catheter with Dual Aspiration with Stent-retriever as Standard approach CRD BADDASSCRD CRD 2024 20243 80% 2025 90% 30%–50%20191,73020302,7902026 24202711 PTA —UltraFreePTA(UltraFree DCB) UltraFree DCB202011202010CE2021UltraFree DCB —UberVanaDCB DCBUberVanaDCB PTA20%CE(UAE)UltraFree DCBPTA ZYLOX Swan 6F512020 ZYLOX Octoplus ZYLOX Octoplus(PE)(DVT) ZYLOX Penguin 420241 ZYLOX Unicorn ZYLOX Unicorn3-0ZYLOX Unicorn5F-22F8F 201510.75201927.432030378.21ZYLOX Unicorn20245 OCTCTO 20243Avinger Inc.AvingerAvinger Inc.(i) PantherisISR(ii) Tigereye ST(iii) LightBox 3OCT2025PantherisLightBox 3 AIOCTOCT OCT 2019PAD4,95020306,230PAD80% Pantheris(OCT)PAD(MAEs)Pantheris(ISR)IDEVISION StudyINSIGHT Study Pantheris DCBDCB20249 Pantheris OCT OCT Tigereye ST(CTO)OCTCTO202411 Tigereye ST LightBox 3 OCT LightBox 3 OCTPatherisTigereye ST(OCT)CTO OCTLightboxXPADOCT LightBox 3 OCT 4,000(DCB)leave nothing behind ePTFE ePTFETASC C/ D II. 782.52023527.848.3%67.7%32.3% 202338.4%(i)CRDSS(ii) 2024202374.5%(i)UltraFreePTA(UltraFree DCB)ZYLOX OctoplusZYLOX Swan(ii)ZYLOX PhoenixZYLOX Penguin2024 202412 31222.6202312 31142.855.9%(i)202312 31(ii)(iii) 202312 31385.045.4%202412 31559.9202312 3172.9%202412 3171.6%(i)(ii) 202412 31233.2202312 31261.010.6%2023109.8202482.9 202412 31174.720231231163.86.6%202312 3131.0%22.3%(i)(ii)(iii) 202412 3191.0202312 31114.120.2%202312 3121.6%202412 3111.6% 202412 311.4202312 311.614.7% 202412 3120.3202312 3114.936.5%2024 43.6202312 3115.8Avinger Inc.AvingerOCTCTO2025 202412 3165.2202312 3177.82024 2023202412 31 (1) (1)H 202312 312,577.1202412 312,509.6127.4202412 31418.1202312 311,086.661.5%202412 311,926.1202312311,388.4202412 31165.4202312 31102.1 202412 3187.0202312 3150.0 202412 3187.02.90%3.40% 202312 311.83%202412 312.93% 202412 311,194.9202312 311,399.414.6% 202412 31 202412 31 202412 31191.3 202412 31 202412 31 202412 31875202312 31765 202412 3112.8158.7202312 31100.6144.6202412 31 III. • • • (CRD)ZYLOX PenguinZYLOXUnicorn • 5820121120121120213 261996720026Guilford Pharmaceuticals Inc.4523CordisCorporationCardinalHealth2002720118 1988619975• 55201672018320213 1995720101020111201292012102014920141020166 1992719957200312 472019120213201622018 20157Medtronic PLCMDT20092013Mystic Pharmaceuticals LimitedInternational Biomedical Ltd 19996200242007820189 3720225 20158CS Capital Co., Ltd.201182015320181020166EpimAb Biotherapeutics Inc.20213 2009201120156 5620201020213 2020199OrbiMedAdvisorsLLCOrbiMed Advisors LLCUBS AG 20204202172138201762019101530 1991519975•2000920029 5520213 19971219971220001220001220041220041220188 2016320106201120101020176 1992719978 妘6120213 20041119867199912 20011200532005420146 2022268829920204600724201572021560113720176202150115820235600177 1986719976200411 502009(eWEAR)2021 20142019 19971999200420042008200820122013 37202311 172021420185202142014201820112014 2011 4520225 2021120166202012Edwards Lifesciences China20062016 2002 3620213 20188202112010720188300529 20196ISO 90012015 ISO134852016 20106 58 4620211 1520183SoucheHolding2016112018320097201610Bank of America Merrill Lynch 200172005320096 201211 620213 220217 5H02190 202412 3137 202412 31100183 202412 312024 7 13.912720231231C2 20253 31 20246 620246 6 20246 613.51(2) 20253 3113.51(2) 3439 3.13 (a)(b) 3.25 38 1818 18 202412 31XV(a)XV78(b)352(c) (1)7,781,257202412 31322,400,744HL (2)WEAEnterprises, LLCWEA20211 21II 202412 318,141,222H1,015,1983,750,196H568,2947,353,613H1,095,8577,488,498H957,709 (3)Highlight Medical LimitedHighlight MedicalOurea Biotech HK LimitedOurea BiotechFive Investment LimitedFive InvestmentHomehealth Investment LimitedHomehealth20213 11IIIIFive InvestmentFive InvestmentHighlight Medical HomehealthHighLightCapital Partners I L.P.HighLight Capital Partners I L.P.HighLight Capital GP I Company LimitedHighLight Capital Partners I L.P.HighLight Capital GP I Company LimitedFive InvestmentHighlight MedicalHomehealthOurea BiotechHL Partners II L.P.HL Partners II L.P.HL GP II Company LimitedHL GP I